Nasr, Y.M., Waly, S.H. and Mokhtar, W.E.L. (2022) Intraperitoneal Bupivacaine with Dexamethasone versus Bupivacaine Alone for Pain Relief after Laparoscopic Bariatric Surgeries: A Randomized Controlled Trial. The Egyptian Journal of Hospital Medicine, 88, 3185-3191.
https://doi.org/10.21608/ejhm.2022.246927

has been cited by the following article:

• TITLE: Intraperitoneal Instillation of Dexmedetomidine vs Dexamethasone as Adjuvant to Bupivacaine for Postoperative Pain in Laparoscopic Cholecystectomy, a Randomized Clinical Trial

  AUTHORS: Ayman Mohamady Eldemrdash, Zaher Z. Zaher, Tarek S. Hemaida, Taha T. Dardeer, Hani M. Raslan, Shawky M. Abdelgalil, Mohmed R. Saad, Mohammed S. Aly

  KEYWORDS: Bupivacaine, Dexmedetomidine, Dexamethasone, Laparoscopic Cholecystectomy

  JOURNAL NAME: Open Journal of Anesthesiology, Vol.15 No.1, January 24, 2025

  ABSTRACT: Background: Intraperitoneal instillation (IPI) of local anesthesia was reported to reduce postoperative pain after laparoscopic surgeries. We aim to evaluate the effectiveness of IPI of bupivacaine + dexmedetomidine versus bupivacaine + dexamethasone on postoperative pain in patients undergoing laparoscopic cholecystectomy (LC). Methods: This randomized clinical trial was carried out on one hundred patients who underwent LC under general anesthesia. Patients were randomly divided into: Group (Dexa): IPI of bupivacaine with dexamethasone and Group (Dexmed): IPI of bupivacaine with dexmedetomidine. Results: The first time to request analgesia was significantly delayed in the dexmed group (P value Conclusions: Intraperitoneal Bupivacaine + Dexmedetomidine provided longer pain-free postoperative duration lower pain score over time, and lesser analgesic consumption.